Trials / Completed
CompletedNCT02823379
Smart Walk: A Physical Activity Program for African American Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Arizona State University · Academic / Other
- Sex
- Female
- Age
- 24 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to test an 8-month, culturally relevant, Smartphone-delivered PA program to improve and maintain high physical levels and reduce cardiometabolic disease risk among obese AA women.
Detailed description
A three-phase study will be used to refine and implement an established theory-based culturally relevant physical activity promotion intervention for obese African American women. Phase 1 (Aim 1a) will include formative research where 25 African American women provide feedback (via 9 focus groups) to further refine the physical activity intervention by specifying the deep structure cultural relevance of the theoretical mediators of self-regulation, self-efficacy, social support, behavioral capability, and outcome expectations.5 Phase 2 will focus on technical development of the refined culturally tailored intervention and 1-month demonstration trial of the Smartphone-delivered physical activity promotion program. Phase 3 (Aims 1b and 1c) will test the intervention and delivery strategy in a two-arm randomized trial where 60 sedentary, obese African American women will receive either the 8-month culturally relevant smartphone-delivered physical activity intervention or a 8-month wellness contact control condition
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Physical Activity | A Smartphone delivered physical activity program |
| BEHAVIORAL | Wellness | A Smartphone delivered wellness intervention focused on topics other than physical activity (e.g., skin care, oral health, and breast exams). |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2016-07-06
- Last updated
- 2020-07-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02823379. Inclusion in this directory is not an endorsement.